[National meetings for complex cases in pediatric radiation oncology: Back on six years experience].

Réunions nationales de cas complexes en radiothérapie pédiatrique : retour sur six années d’expérience.
Cancer Collegial Collégial Pediatric Pédiatrie Radiation therapy Radiothérapie

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 07 03 2022
revised: 07 04 2022
accepted: 14 04 2022
pubmed: 9 8 2022
medline: 26 10 2022
entrez: 8 8 2022
Statut: ppublish

Résumé

Pediatric cancers are rare, representing almost 2,500 new cases each year in France meaning 1% of all cancers. Since 2012, a twice-monthly national web-based conference was held in France. Any patient with a pediatric type cancer requiring radiotherapy can be discussed. It aims at answering the physician with specific radiation therapy questions on rare and complex indications, at promoting the use of referential and the inclusion into clinical protocols. From 2012 to 2018, 1,078 cases were discussed for 940 patients in 142 meetings. Mean age was 10 years old (4 months to 45 years). The mean number of attendants was 6 (2 to 32). We review in this paper the main clinical features discussed in the web-conference and the decision of the web-conference. In 85% cases, the first treatment proposed was mostly accepted, but in 15%, other proposals were done (modifications of target volumes, doses or indications). Between 2012 and 2018, more than 1,000 pediatric irradiation cases were discussed in our web-based conference leading to 15% of change in radiation protocol. The rarity and the complexity of these situations need those meetings. They provide a place to improve the global knowledge and the quality of the treatments provided.

Identifiants

pubmed: 35940945
pii: S0007-4551(22)00188-6
doi: 10.1016/j.bulcan.2022.04.011
pii:
doi:

Types de publication

Review English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

1177-1184

Informations de copyright

Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Ronan Tanguy (R)

Centre Léon-Bérard, département de radiothérapie, Lyon, France. Electronic address: ronan.tanguy@lyon.unicancer.fr.

Claire Alapetite (C)

Institut Curie, département de radiothérapie, Paris, France.

Anne Laprie (A)

Institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, département d'oncologie radiothérapie, Toulouse, France.

Céline Vigneron (C)

Institut de cancérologie de Strasbourg-Europe (ICANS), service de radiothérapie, Strasbourg, France.

Stéphanie Bolle (S)

Institut Gustave-Roussy, département d'oncologie radiothérapie, Villejuif, France.

Julien Wellmant (J)

Institut du cancer de Montpellier, département de radiothérapie, Montpellier, France.

Aymeri Huchet (A)

CHU de Bordeaux, service de radiothérapie, Bordeaux, France.

Dinu Stefan (D)

Centre François-Baclesse, département de radiothérapie, Caen, France.

Hélène Potet (H)

Centre hospitalier de Rodez, département de radiothérapie, Rodez, France.

Valérie Bernier (V)

Institut de cancérologie de Lorraine, service de radiothérapie, Vandœuvre-lès-Nancy, France.

Emmanuel Jouglar (E)

Institut Curie, département de radiothérapie, Paris, France; Institut de cancérologie de l'Ouest, département de radiothérapie, Nantes-Saint-Herblain, France.

Alexandre Escande (A)

Centre Oscar-Lambret, UMR 9189, université de Lille, faculté de médecine H. Warembourg, département universitaire de radiothérapie, laboratoire CRIStAL, Lille, France.

Xavier Murraciole (X)

La Timone Hospital, Assistance Publique-Hôpitaux de Marseille (AP-HM), département de radiothérapie, Marseille, France.

Julie Leseur (J)

Centre Eugene-Marquis, département de radiothérapie, Rennes, France.

Gilles Truc (G)

Georges François-Leclerc Cancer Center, département de radiothérapie, Dijon, France.

Sophie Chapet (S)

CHU, département de radiothérapie, Tours, France.

Caroline Pasteris (C)

CHU de Grenoble, département de radiothérapie, Grenoble, France.

Pierre-Yves Bondiau (PY)

Centre Antoine-Lacassagne, département de radiothérapie, Nice, France.

Line Claude (L)

Centre Léon-Bérard, département de radiothérapie, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH